These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29741260)

  • 1. Acute myeloid leukaemia: How to combine multiple tools.
    Merino A; Boldú L; Ermens A
    Int J Lab Hematol; 2018 May; 40 Suppl 1():109-119. PubMed ID: 29741260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
    Vardiman JW
    Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic work-up of acute myeloid leukemia.
    Weinberg OK; Sohani AR; Bhargava P; Nardi V
    Am J Hematol; 2017 Mar; 92(3):317-321. PubMed ID: 28066929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular Genetic Testing for Acute Myeloid Leukemia].
    Janečková V; Semerád L; Ježíšková I; Dvořáková D; Čulen M; Šustková Z; Mayer J; Ráčil Z
    Klin Onkol; 2016; 29(6):411-418. PubMed ID: 27951719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute myeloid leukemia with bone marrow erythroblastosis: about one case illustrating the new WHO classification (2008)].
    Vincenot A; Abarah W; Frayfer J; Mahfouz I; Andre-Kerneis E
    Ann Biol Clin (Paris); 2011; 69(3):343-7. PubMed ID: 21659053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant and opportunistic leukemic clones: proposal for a pathogenesis-oriented classification in acute myeloid leukemia.
    Cucuianu A
    Med Hypotheses; 2005; 65(1):107-13. PubMed ID: 15893127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical algorithm for acute myeloid leukaemia diagnosis following the updated 2022 classifications.
    Della Porta MG; Martinelli G; Rambaldi A; Santoro A; Voso MT
    Crit Rev Oncol Hematol; 2024 Jun; 198():104358. PubMed ID: 38615870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Malfeasance Mediating Myeloid Malignancies: The Genetics of Acute Myeloid Leukemia.
    King RL; Bagg A
    Methods Mol Biol; 2017; 1633():1-17. PubMed ID: 28735477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferations.
    Wertheim GB; Hexner E; Bagg A
    Mol Diagn Ther; 2012 Dec; 16(6):357-69. PubMed ID: 23184342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia: conventional cytogenetics, FISH, and moleculocentric methodologies.
    Morrissette JJ; Bagg A
    Clin Lab Med; 2011 Dec; 31(4):659-86, x. PubMed ID: 22118743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients.
    Bacher U; Kern W; Schnittger S; Hiddemann W; Schoch C; Haferlach T
    Ann Hematol; 2005 Nov; 84(12):785-91. PubMed ID: 16132906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A classification of acute leukaemia for the 1990s.
    Catovsky D; Matutes E; Buccheri V; Shetty V; Hanslip J; Yoshida N; Morilla R
    Ann Hematol; 1991 Feb; 62(1):16-21. PubMed ID: 2031964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways.
    Bullinger L; Döhner K; Döhner H
    J Clin Oncol; 2017 Mar; 35(9):934-946. PubMed ID: 28297624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology Consultation on Gene Mutations in Acute Myeloid Leukemia.
    Ziai JM; Siddon AJ;
    Am J Clin Pathol; 2015 Oct; 144(4):539-54. PubMed ID: 26386075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myeloid leukaemia and myelodysplastic syndromes with 50% or greater erythroblasts: a diagnostic conundrum.
    Wong E; Juneja S
    Pathology; 2015 Jun; 47(4):289-93. PubMed ID: 25938365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolving molecular genetic landscape in acute myeloid leukaemia.
    Sanders MA; Valk PJ
    Curr Opin Hematol; 2013 Mar; 20(2):79-85. PubMed ID: 23380602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of minimal residual disease in acute myelogenous leukemia.
    Raanani P; Ben-Bassat I
    Acta Haematol; 2004; 112(1-2):40-54. PubMed ID: 15179004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2016 WHO classification of acute myeloid leukemia: What the practicing clinician needs to know.
    Arber DA
    Semin Hematol; 2019 Apr; 56(2):90-95. PubMed ID: 30926096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification.
    Kansal R
    Cancer Biol Med; 2016 Mar; 13(1):41-54. PubMed ID: 27144061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.